MUSC Catalyst News

As COVID-19 cases plateau in Charleston area, MUSC COVID-19 Epidemiology Intelligence Project warns of faster-spreading variants.

Even after accounting for factors associated with bad behavior, researchers found Black elementary children more likely to be suspended than white children.

Applications for the increasingly diverse Medical Scientist Training Program at MUSC are up substantially, attracting “cream of the crop.”

A Hollings clinical trial is testing the impact of changing the order of treatments for metastatic prostate cancer patients.

Dr. Elizabeth Hill has joined MUSC Hollings Cancer Center as the new director of the Biostatistics Shared Resource.

Some experts feared in-person school during pandemic would cause surge in cases. Data show that hasn’t happened in Charleston County.

Dr. Danielle Scheurer, MUSC Health System's chief quality officer, talks all things vaccine.

A portion of the proceeds from this year's Head for the Cure Charleston 5K will support brain cancer research at Hollings.

MUSC Health works to expand access to monoclonal antibody infusions to treat COVID-19 after seeing good results in the first batch of patients in late 2020.

A product conceived of by MUSC Health clinicians, developed by ZIAN engineers and now manufactured by Rhythmlink will make the operating room a safer place.